Grants and Contributions:
Title:
2425-HQ-000031
Agreement Number:
2425-HQ-000031
Agreement Value:
$162,479,793.00
Agreement Date:
Dec 20, 2024 - Mar 31, 2027
Description:
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Organization:
Health Canada
Expected Results:
Improved collaboration across provincial/territorial drug plans related to drugs for rare decisions decision-making.
Canadians with rare diseases have better access to screening and diagnostic services they need.
Location:
Edmonton, Alberta, CA T5J 1S6
Reference Number:
271-2024-2025-Q3-00060
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Type:
Government
Recipient's Legal Name:
Government of Alberta - Ministry of Health
Program:
National Strategy for Drugs for Rare Diseases Program
Program Purpose:
Canadian Health Systems and Programs